Synchron

Brooklyn, United States Founded: 2016 • Age: 10 yrs
Implantable bioelectronics are developed for neurological condition treatments.
Request Access

About Synchron

Synchron is a company based in Brooklyn (United States) founded in 2016 by Rahul Sharma. It operates as a HealthTech. Synchron has raised $325 million across 6 funding rounds from investors including Metis, NIH and Khosla Ventures. Synchron offers products and services including Synchron BCI. Synchron operates in a competitive market with competitors including ONWARD, Nalu Medical, Atlantic Therapeutics, MyndTec and SpineX, among others.

  • Headquarter Brooklyn, United States
  • Founders Rahul Sharma
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $325 M (USD)

    in 6 rounds

  • Latest Funding Round
    $200 M (USD), Series D

    Nov 06, 2025

  • Investors
    Metis

    & 29 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Synchron

Synchron offers a comprehensive portfolio of products and services, including Synchron BCI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

A device enabling thought-controlled interaction with digital tools.

People of Synchron
Headcount 10-50
Employee Profiles 48
Board Members and Advisors 13
Employee Profiles
People
J Mocco
Chief Medical Officer
People
Amos Meltzer
Chief Legal Officer
People
Matthew Matuscak
Lead Software Architect
People
Kurt Haggstrom
Chief Commercial Officer (cco)

Unlock access to complete

Funding Insights of Synchron

Synchron has successfully raised a total of $325M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $200 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series D — $200.0M
  • First Round

    (04 Apr 2017)

  • Investors Count 30
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2025 Amount Series D - Synchron Valuation Double Point Ventures
Dec, 2022 Amount Series C - Synchron Valuation Arch Venture Partners
Dec, 2021 Amount Grant - Synchron Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Synchron

Synchron has secured backing from 30 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Metis, NIH and Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Venture capital firm focused on life science companies
Founded Year Domain Location
Investment management and philanthropic ventures linked to Bezos Expeditions.
Founded Year Domain Location
Tech-enabled businesses are funded by Greenoaks venture capital firm.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Synchron

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Synchron

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Synchron Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Synchron

Synchron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ONWARD, Nalu Medical, Atlantic Therapeutics, MyndTec and SpineX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic devices for spinal cord injuries are developed and delivered.
domain founded_year HQ Location
Developer of a neurostimulation system for managing intractable chronic pain
domain founded_year HQ Location
Non-invasive wearable devices for pelvic floor strengthening are developed.
domain founded_year HQ Location
Functional electrical stimulation therapy is developed for upper limb paralysis.
domain founded_year HQ Location
Neuromodulation devices for neurological disorders are developed and offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Synchron

Frequently Asked Questions about Synchron

When was Synchron founded?

Synchron was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Synchron located?

Synchron is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.

Is Synchron a funded company?

Synchron is a funded company, having raised a total of $325M across 6 funding rounds to date. The company's 1st funding round was a Grant of $990K, raised on Apr 04, 2017.

What does Synchron do?

Synchron is engaged in developing brain-computer interface technology to assist individuals with movement limitations. The companys solutions are designed to enable thought-controlled interaction with digital devices, primarily targeting autonomy and social connection. Their innovative approach includes a minimally invasive endovascular procedure, avoiding traditional open brain surgery. Synchron operates within the healthcare and medical device sector, focusing on neurotechnology to address human body limitations.

Who are the top competitors of Synchron?

Synchron's top competitors include ONWARD, Nalu Medical and MyndTec.

What products or services does Synchron offer?

Synchron offers Synchron BCI.

Who are Synchron's investors?

Synchron has 30 investors. Key investors include Metis, NIH, Khosla Ventures, Arch Venture Partners, and University of Melbourne.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available